Laboratorios Garden House

Name

Laboratorios Garden House

Legal name

Laboratorios Garden House

Website

http://www.gardenhouse.cl

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Medicinal and Botanical Manufacturing (325411), Food (Health) Supplement Retailers (456191)

SIC

Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro industry

PRIMARYCRADAGAD

Herbal & Botanical Supplements

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Vitamins, Supplements & Sports Nutrition

SECONDARYCRADAGAF

Probiotics & Digestive Health Supplements

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Vitamins, Supplements & Sports Nutrition

SECONDARYCRADAGAB

Vitamins & Minerals (Single Nutrients)

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Vitamins, Supplements & Sports Nutrition

Keywords

• Pharmaceutical manufacturing
• Over-the-counter medications
• Dietary supplements
• Nutraceutical products
• Prescription drugs

Headquarters

HQ city

San Bernardo

HQ country

Chile

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. OTC Medications: Over-the-counter medications sold directly to consumers through pharmacies and retail channels. Products include Ciruelax, FinArtrit, Contravaris, and other laxatives and health products.
2. Prescription (RX) Drugs: Prescription pharmaceutical products covering various areas of medicine for treating specific health conditions.
3. Natural Nutraceuticals: Natural dietary supplements including products in various formats (tablets, capsules, powder, jelly, liquid, tea) for health and wellness support.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Laboratorios Garden House manufactures and distributes over-the-counter (OTC) medications, prescription (RX) drugs, and natural nutraceuticals from two plants in San Bernardo, Chile. Its flagship product line is centered on Ciruelax, the #1 laxative brand in Latin America, alongside joint care (FinArtrit), beauty, energy and vitality, and digestive health supplements sold in multiple formats including tablets, capsules, powder, jelly, liquid, and tea. Products are distributed through pharmacies and retail channels in 20 countries including the USA, Australia, Canada, and throughout Latin America.

Product overview

Garden House Laboratories is a pharmaceutical company producing over-the-counter (OTC) medications, prescription (RX) drugs, and natural nutraceuticals. The portfolio includes core products like Ciruelax (the #1 laxative brand in Latin America since 1987), Prunelax, FinArtrit, and Contravaris, along with line extensions such as FinArtrit Advance and Dolo FinArtrit. Additional products include Accualaxan, Ginkgomax, Hidrolageno, Celus, HQ10, Hydroprotein, and Rica C. Products span categories including beauty, bones and joints, digestion, and energy and vitality. The company operates two manufacturing plants (medicines and supplements) meeting international standards, producing 319 million tablets and 337 tons of jelly in 2022, with distribution across 20 countries including the USA, Australia, and Canada.

Differentiator

Problem solved

Functional benefit

Brands

• Ciruelax: Laxative product, flagship brand, in the market since 1987
• Prunelax
• FinArtrit
• Contravaris
• Dolo-FinArtrit
• FinArtrit Advance
• Accualaxan
• Ginkgomax
• HQ10
• Rica-C
• Hydroprotein
• Celus-C
• Hidrolageno

Products and services

• Ciruelax Flagship laxative product and #1 laxative brand in Latin America per IQVIA 2021, in the market since 1987. Sold to consumers in multiple formats (tablets, capsules, powder, jelly, liquid, tea) for digestive health.
• Prunelax Natural laxative supplement available in multiple formats, distributed internationally including Australia and Canada.
• FinArtrit Joint health and arthritis management product, part of the core Garden House portfolio.
• FinArtrit Advance Advanced formulation of FinArtrit for enhanced joint care and arthritis support.
• Dolo-FinArtrit Pain relief formulation combining FinArtrit's joint health benefits with analgesia for arthritis symptoms.
• Contravaris Core product retained after the 1999-2001 portfolio optimization, part of Garden House's optimized OTC offering.
• Accualaxan Laxative product in the Garden House portfolio for digestive health.
• Ginkgomax Ginkgo biloba-based natural supplement for cognitive health and circulation support.
• Celus-C Vitamin C dietary supplement product.
• Rica-C Vitamin C dietary supplement product.
• HQ10 Dietary supplement product in the Garden House portfolio.
• Hydroprotein Protein dietary supplement product in the Garden House portfolio.
• Hidrolageno Hydrogen-based dietary supplement product in the Garden House portfolio.

Quantifiable outcome

• 319 million tablets manufactured in 2022
• +3 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• MegalabsflagshipStrategic or Co-development Partner · 1 January 2018In 2018, Garden House Laboratories was acquired by Megalabs, an international pharmaceutical conglomerate. This acquisition expanded Garden House's reach within the Megalabs network and provided access to greater resources for international expansion and product development.

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Boehringer Ingelheim (Dulcolax): Boehringer Ingelheim's Dulcolax is one of the world's leading OTC laxative brands. It is a direct competitor to Ciruelax/Prunelax in the same laxative category, with global retail distribution that Garden House must compete against in every new market.
• Church & Dwight (Fleet, Phillips'): Church & Dwight owns Fleet laxatives and other digestive-health brands. It competes directly with Garden House in the OTC laxative space and shares a similar multi-category consumer health product model.

Broad incumbents

• Bayer Consumer Health (MiraLAX): Bayer's consumer health division markets MiraLAX and a broad OTC portfolio. As a global incumbent with significantly larger R&D and marketing budgets, Bayer represents the most powerful competitor Garden House faces as it expands into North America and other developed markets.
• Sanofi Consumer Healthcare: Sanofi operates a global OTC and consumer healthcare portfolio including digestive health products. It is a broad incumbent with the scale, regulatory expertise, and retail relationships that compete with Garden House's specialty positioning.
• GSK Consumer Healthcare: GSK's consumer health division markets a wide OTC portfolio including digestive health and pain relief. It competes with Garden House across multiple categories (joint care, OTC, supplements) and represents a benchmark for global consumer pharma scale.
• Perrigo Company: Perrigo is a leading global OTC and private-label consumer healthcare manufacturer with a meaningful presence in digestive health. It competes with Garden House through private-label laxative and supplement alternatives across multiple geographies.
• Reckitt Benckiser (Mucofalk, Nurofen): Reckitt's consumer health division markets digestive and pain brands globally. It shares Garden House's OTC + consumer health model and is a relevant incumbent competitor as Garden House expands internationally.

Regional players

• Megalabs: Megalabs is the international pharmaceutical conglomerate that acquired Garden House in 2018. It is comparable as the parent and as a regional Latin American pharma group with overlapping product categories (OTC, prescription, supplements).
• Laboratorios Bagó: Laboratorios Bagó is a Latin American pharmaceutical company with OTC and prescription portfolios. It is comparable as a regional pharma peer with similar geographic footprint and channel strategy through pharmacies and healthcare providers.
• Eurofarma: Eurofarma is a large Latin American pharmaceutical company with OTC, prescription, and consumer health lines. It is a regional peer with similar geographic footprint across Brazil and Latin America where Garden House competes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/laboratorios-garden-house
• Facebookfacebook.com/LabGardenHouse

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratorios Garden House